Poseida Therapeutics, Inc(NASDAQ:PSTX) 
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company is developing P-BCMA-101, an autologous chimeric antigen receptor T cell (CAR-T) targeting B cell maturation antigen that is in Phase II ...
Website: http://www.poseida.com
Founded: 2014
Full Time Employees: 186
CEO: Eric M. Ostertag
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-12
P
O 3.38
H 3.62
L 3.23
C 3.36
V 555,449
10EMA 3.36
20EMA 3.36
60EMA 3.36
120EMA 3.36
250EMA 3.36